| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/16/2006 | WO2006029125A2 Methods and compositions for treating hypercholesterolemia |
| 03/16/2006 | WO2006029088A2 Methods for restoring immune balance for the treatment of t-cell mediated diseases |
| 03/16/2006 | WO2006029085A1 Antimicrobial cementitious compositions |
| 03/16/2006 | WO2006029046A2 Use of leptin in wound healing |
| 03/16/2006 | WO2006029028A2 Improved apo e analogs and methods for their use |
| 03/16/2006 | WO2006028993A2 Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides |
| 03/16/2006 | WO2006028991A2 Composition and method for prevention or treatment of stomatits |
| 03/16/2006 | WO2006028939A1 Controlled and directed local delivery of anti-inflammatory compositions |
| 03/16/2006 | WO2006028836A1 Wound healing |
| 03/16/2006 | WO2006028724A1 Stretch mark treatment with botulinum toxic |
| 03/16/2006 | WO2006028714A1 Muteins of fibroblast growth factor 21 |
| 03/16/2006 | WO2006028684A2 Phytases, nucleic acids encoding them and methods of making and using them |
| 03/16/2006 | WO2006028645A2 Method for remodeling bone and related sutures |
| 03/16/2006 | WO2006028496A2 Lesion repair polymerase compositions |
| 03/16/2006 | WO2006028492A2 hC1Q/TNF7 AND USES THEREOF |
| 03/16/2006 | WO2006027780A2 Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same |
| 03/16/2006 | WO2006027701A2 Fas associated factor 1 |
| 03/16/2006 | WO2006027545A2 Method |
| 03/16/2006 | WO2006027116A2 P277 peptide formulations or variants thereof having optimised stability |
| 03/16/2006 | WO2006026998A1 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 03/16/2006 | WO2006006167A3 Compositions and methods for dermatological wound healing |
| 03/16/2006 | WO2006004633A3 A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 03/16/2006 | WO2006002854A3 Tie receptor and tie ligand materials and methods for modulating female fertility |
| 03/16/2006 | WO2005121168A3 Heparin binding peptide |
| 03/16/2006 | WO2005117584A3 Improved transmucosal delivery of peptides and proteins |
| 03/16/2006 | WO2005117538A9 METHODS AND COMPOSITIONS FOR INHIBITING ABAD/Aβ PROTEIN INTERACTION |
| 03/16/2006 | WO2005115441A3 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 03/16/2006 | WO2005112970A3 Use of gelsolin to treat infections |
| 03/16/2006 | WO2005111008A3 Compounds for enzyme inhibition |
| 03/16/2006 | WO2005110457A3 Treatment of eating disorders and induction of lipolysis |
| 03/16/2006 | WO2005110013A3 Methods, compositions, and preparations for delivery of immune response modifiers |
| 03/16/2006 | WO2005106488A3 Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) |
| 03/16/2006 | WO2005103076A3 Erythropoietin protein variants |
| 03/16/2006 | WO2005102374A3 Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes |
| 03/16/2006 | WO2005097160A3 Modulation of nkg2d |
| 03/16/2006 | WO2005094891A3 Method for solubilising peptide mixtures |
| 03/16/2006 | WO2005094870A3 Use of osteopontin fragment svvglr-derived peptides for the treatment of ischemic diseases |
| 03/16/2006 | WO2005091991A3 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders |
| 03/16/2006 | WO2005087926A3 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 03/16/2006 | WO2005077007A3 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 03/16/2006 | WO2005070468A3 Transglutaminase mediated conjugation of peptides |
| 03/16/2006 | WO2005070148A3 Methods of using high affinity atiii variants |
| 03/16/2006 | WO2005060998A3 Methods of modulating cytokine activity; related reagents |
| 03/16/2006 | WO2005037203A3 Methods and reagents for the treatment of immunoinflammatory disorders |
| 03/16/2006 | WO2005035759A3 RNA INTERFERENCE MEDIATED INHIBITION OF HYPOXIA INDUCIBLE FACTOR 1 (HIF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/16/2006 | WO2004056318A3 Method for treating amyloid disease |
| 03/16/2006 | WO2004033663A3 Carbohydrate-based synthetic vaccines for hiv |
| 03/16/2006 | WO2004031352A3 Interferon variants with improved properties |
| 03/16/2006 | WO2004024072A3 Novel compositions and methods for the treatment of immune related diseases |
| 03/16/2006 | WO2004019881A3 Hypocretin administration as a treatment for obesity |
| 03/16/2006 | WO2004019857A3 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
| 03/16/2006 | WO2004016733A3 Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| 03/16/2006 | US20060058835 Bioabsorbable polymeric implants and a method of using the same to create occlusions |
| 03/16/2006 | US20060058512 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 03/16/2006 | US20060058504 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 03/16/2006 | US20060058503 Process for preparing glycopeptide derivatives |
| 03/16/2006 | US20060058399 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 03/16/2006 | US20060058394 Medicine of post-traumatic stress disorder |
| 03/16/2006 | US20060058307 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 03/16/2006 | US20060058258 Gene transcription and ionizing radiation: methods and compositions |
| 03/16/2006 | US20060058256 Capable of inducing breakdown of mrna enzymes that break down connective tissue; particularly suited for treating degenerative skin disorders; pharmaceutical and cosmetic compositions for topical application and which contain the oligoribonucleotides |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060058252 Methods and materials for treating human papillomavirus infections |
| 03/16/2006 | US20060058242 Dipeptide derivatives |
| 03/16/2006 | US20060058241 Methods of treating disorders having a component of mercury toxicity |
| 03/16/2006 | US20060058240 Peptides and compounds that bind to a receptor |
| 03/16/2006 | US20060058239 Use of the insulin-like-growth factor I isoform MGF for the treatment of neurological disorders |
| 03/16/2006 | US20060058238 Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
| 03/16/2006 | US20060058237 p49/STRAP is a novel protein involved in gene regulation and cell proliferation |
| 03/16/2006 | US20060058236 Endogenously-formed conjugate of albumin |
| 03/16/2006 | US20060058235 Long lasting synthetic glucagon like peptide (GLP-1) |
| 03/16/2006 | US20060058234 VEGF traps and therapeutic uses thereof |
| 03/16/2006 | US20060058233 Administering a polypeptide comprising an immunogenic fragment of alpha-synuclein that induces a response of antibodies that specifically bind to an epitope within residues 70-140 of human alpha-synuclein; Parkinson's disease |
| 03/16/2006 | US20060058232 Methods of treating cancer using a modified endostatin protein |
| 03/16/2006 | US20060058231 Variants of human bone morphogenetic proteins and other cysteine knot cytokine proteins with improved properties, including increased expression yield, expression in absence of a pro-domain, increased solubility, increased specific activity, altered receptor, co-receptor, inhibitor specificity |
| 03/16/2006 | US20060058230 Analogs of parathyroid hormone and pth-related protein as bone anabolic agents |
| 03/16/2006 | US20060058229 Peptides and methods for cell death regulation |
| 03/16/2006 | US20060058228 nine amino acid, disulfide-constrained peptide that selectively bound and was internalized into colon cancer cells; exhibit decreased or a substantially nonexistent immunogenicity in an in vivo system |
| 03/16/2006 | US20060058227 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 03/16/2006 | US20060058226 Gd3-mimetic peptides |
| 03/16/2006 | US20060058225 Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 03/16/2006 | US20060058224 Methods of treating obesity with combination therapeutics |
| 03/16/2006 | US20060058223 TAJ in neuronal function |
| 03/16/2006 | US20060058222 May be coupled with endorphin, enkephalin, dynorphin or endomorphin; for traversing blood brain barrier |
| 03/16/2006 | US20060058221 Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders |
| 03/16/2006 | US20060058219 Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders |
| 03/16/2006 | US20060058218 Solid phase conjugation of complexing agents and targeting moieties |
| 03/16/2006 | US20060058217 Compositions and methods for treatment of ovarian cancer |
| 03/16/2006 | US20060057717 Human bone accessory cells |
| 03/16/2006 | US20060057678 Chimeric proteins for diagnosis and treatment of diabetes |
| 03/16/2006 | US20060057675 Human toll homologue |
| 03/16/2006 | US20060057669 Inactive transcription factor tif-ia and uses thereof |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057666 Human g protein coupled receptor |
| 03/16/2006 | US20060057665 Galectin-14 therapeutic molecule and uses thereof |
| 03/16/2006 | US20060057664 Polypeptides and polynucleotides encoding same |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057649 Screening method and anti-tumor drug candidate obtained therefrom |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |